Finance

Lists
4582:TYO
Symbio Pharmaceuticals Ltd
55,00 JP¥
-1,79%
(-1,00) 1D
8 հոկ, 15:30:00 GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4582...
Open
56 JP¥
High
56 JP¥
Low
55 JP¥
Mkt. cap
4,57 մլրդ
Avg. vol.
664,86 հզր
Volume
195,80 հզր
52-wk high
229 JP¥
52-wk low
53 JP¥
EPS
-98 JP¥
Shares outstanding
82,40 մլն
No. of employees
91
Open
56 JP¥
High
56 JP¥
Low
55 JP¥
Mkt. cap
4,57 մլրդ
Avg. vol.
664,86 հզր
Volume
195,80 հզր
52-wk high
229 JP¥
52-wk low
53 JP¥
EPS
-98 JP¥
Shares outstanding
82,40 մլն
No. of employees
91
News stories
From web sources and news partners
About Symbio Pharmaceuticals Ltd
CEO-
Employees91
Founded25 մրտ, 2005 թ.
HeadquartersՄինատո, Տոկիո, Ճապոնիա
Sector-
Websitesymbiopharma.com
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
324,17 մլն
336,19 մլն
233,46 մլն
235,54 մլն
Cost of goods sold
122,29 մլն
84,64 մլն
60,63 մլն
71,37 մլն
Cost of revenue
122,29 մլն
84,64 մլն
60,63 մլն
71,37 մլն
Research and development expenses
868,70 մլն
846,40 մլն
1,99 մլրդ
-1,99 մլրդ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
518,54 մլն
506,73 մլն
522,11 մլն
3,45 մլրդ
Operating expense
1,39 մլրդ
1,35 մլրդ
2,51 մլրդ
1,46 մլրդ
Total operating expenses
1,51 մլրդ
1,44 մլրդ
2,57 մլրդ
1,53 մլրդ
Operating income
-1,19 մլրդ
-1,10 մլրդ
-2,34 մլրդ
-1,29 մլրդ
Other non operating income
-1,57 մլն
14,49 մլն
-6,26 մլն
85,26 մլն
EBT including unusual items
-1,20 մլրդ
-1,19 մլրդ
-2,39 մլրդ
-1,21 մլրդ
EBT excluding unusual items
-1,20 մլրդ
-1,09 մլրդ
-2,39 մլրդ
-1,22 մլրդ
Income tax expense
-3,66 մլն
18,88 մլն
13,97 մլն
4,03 մլն
Effective tax rate
0,30%
-1,58%
-0,58%
-0,33%
Other operating expenses
-
-
-
-
Net income
-1,20 մլրդ
-1,21 մլրդ
-2,40 մլրդ
-1,22 մլրդ
Net profit margin
-369,09%
-360,02%
-1 028,60%
-516,94%
Earnings per share
-
-
-
-
Interest and investment income
1,73 մլն
653,00 հզր
2,25 մլն
-
Interest expense
-29,04 մլն
-11,12 մլն
-16,63 մլն
-16,62 մլն
Net interest expenses
-27,31 մլն
-10,47 մլն
-14,38 մլն
-16,62 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps